Geðrof í kjölfar ADHD-lyfjameðferðar : Sjúkratilfelli
| dc.contributor.author | Gudbrandsdottir, Ragna Kristin | |
| dc.contributor.author | Sigurðsson, Engilbert | |
| dc.contributor.author | Ingimarsson, Oddur | |
| dc.contributor.department | Læknadeild | |
| dc.date.accessioned | 2025-11-20T09:20:39Z | |
| dc.date.available | 2025-11-20T09:20:39Z | |
| dc.date.issued | 2023-07-01 | |
| dc.description | Publisher Copyright: © 2023 Laeknafelag Islands. All rights reserved. | en |
| dc.description.abstract | In view of the ongoing rise of ADHD prescriptions among adults in Iceland, it is important that doctors are aware that psychosis is a rare but at times a serious adverse reaction to such treatment. In 2022 5% of adults were prescribed medication to treat ADHD in Iceland. In this case report we present a case of methylphenidate-induced psychosis in a young man with no previous history of psychotic episodes who required admission to the psychiatric intensive care unit. | en |
| dc.description.version | Peer reviewed | en |
| dc.format.extent | 4 | |
| dc.format.extent | 657878 | |
| dc.format.extent | 346-349 | |
| dc.identifier.citation | Gudbrandsdottir, R K, Sigurðsson, E & Ingimarsson, O 2023, 'Geðrof í kjölfar ADHD-lyfjameðferðar : Sjúkratilfelli', Læknablaðið, vol. 109, no. 7-8, pp. 346-349. https://doi.org/10.17992/lbl.2023.0708.753 | en |
| dc.identifier.doi | 10.17992/lbl.2023.0708.753 | |
| dc.identifier.issn | 1670-4959 | |
| dc.identifier.other | 168615526 | |
| dc.identifier.other | f7028fc2-17c0-4610-8896-40509ac36c8a | |
| dc.identifier.other | 85163651364 | |
| dc.identifier.other | 37378652 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.11815/7293 | |
| dc.language.iso | is | |
| dc.relation.ispartofseries | Læknablaðið; 109(7-8) | en |
| dc.relation.url | https://www.scopus.com/pages/publications/85163651364 | en |
| dc.rights | info:eu-repo/semantics/openAccess | en |
| dc.subject | ADHD | en |
| dc.subject | methylphenidate | en |
| dc.subject | psychosis | en |
| dc.subject | ADHD | en |
| dc.subject | methylphenidate | en |
| dc.subject | psychosis | en |
| dc.subject | Young Adult | en |
| dc.subject | Central Nervous System Stimulants/adverse effects | en |
| dc.subject | Humans | en |
| dc.subject | Methylphenidate/adverse effects | en |
| dc.subject | Male | en |
| dc.subject | Psychotic Disorders/diagnosis | en |
| dc.subject | Iceland/epidemiology | en |
| dc.subject | Attention Deficit Disorder with Hyperactivity/diagnosis | en |
| dc.subject | General Medicine | en |
| dc.title | Geðrof í kjölfar ADHD-lyfjameðferðar : Sjúkratilfelli | is |
| dc.type | /dk/atira/pure/researchoutput/researchoutputtypes/contributiontojournal/article | en |
Skrár
Original bundle
1 - 1 af 1
- Nafn:
- Ge_rof_kj_lfar_ADHD-lyfjame_fer_ar.pdf
- Stærð:
- 642.46 KB
- Snið:
- Adobe Portable Document Format